A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)
Conditions
- Scleroderma, Diffuse
- Scleroderma, Systemic
Interventions
- DRUG: Abatacept
- DRUG: Placebo
Sponsor
Stanford University
Collaborators